BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2450528)

  • 1. Localization of the rubella E1 epitopes.
    Terry GM; Ho-Terry L; Londesborough P; Rees KR
    Arch Virol; 1988; 98(3-4):189-97. PubMed ID: 2450528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological characterisation of the rubella E 1 glycoprotein. Brief report.
    Ho-Terry L; Terry GM; Cohen A; Londesborough P
    Arch Virol; 1986; 90(1-2):145-52. PubMed ID: 2425779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localization of the virus neutralizing and hemagglutinin epitopes of E1 glycoprotein of rubella virus.
    Chaye H; Chong P; Tripet B; Brush B; Gillam S
    Virology; 1992 Aug; 189(2):483-92. PubMed ID: 1379391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure of rubella E1 glycoprotein epitopes established by multiple peptide synthesis.
    Lozzi L; Rustici M; Corti M; Cusi MG; Valensin PE; Bracci L; Santucci A; Soldani P; Spreafico A; Neri P
    Arch Virol; 1990; 110(3-4):271-6. PubMed ID: 1690535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies directed to E1 glycoprotein of rubella virus.
    Umino Y; Sato TA; Katow S; Matsuno T; Sugiura A
    Arch Virol; 1985; 83(1-2):33-42. PubMed ID: 2578781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E1 glycoprotein of rubella virus carries an epitope that binds a neutralizing antibody.
    Trudel M; Nadon F; Séguin C; Amarouch A; Payment P; Gillam S
    J Virol Methods; 1985 Dec; 12(3-4):243-50. PubMed ID: 2422194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of N-linked glycosylation on the antigenicity and immunogenicity of rubella virus E1 glycoprotein.
    Qiu Z; Tufaro F; Gillam S
    Virology; 1992 Oct; 190(2):876-81. PubMed ID: 1381541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An antibody- and synthetic peptide-defined rubella virus E1 glycoprotein neutralization domain.
    Wolinsky JS; Sukholutsky E; Moore WT; Lovett A; McCarthy M; Adame B
    J Virol; 1993 Feb; 67(2):961-8. PubMed ID: 7678312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recognition of synthetic peptides with sequences of rubella virus E1 polypeptide by antibodies and T lymphocytes.
    Ilonen J; Seppänen H; Närvänen A; Korkolainen M; Salmi AA
    Viral Immunol; 1992; 5(3):221-8. PubMed ID: 1384533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequence variation and biological activity of rubella virus isolates.
    Londesborough P; Ho-Terry L; Terry G
    Arch Virol; 1995; 140(3):563-70. PubMed ID: 7537491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleotide sequence analysis of a major antigenic domain of the E1 glycoprotein of 22 rubella virus isolates.
    Bosma TJ; Best JM; Corbett KM; Banatvala JE; Starkey WG
    J Gen Virol; 1996 Oct; 77 ( Pt 10)():2523-30. PubMed ID: 8887486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping T-cell epitopes of rubella virus structural proteins E1, E2, and C recognized by T-cell lines and clones derived from infected and immunized populations.
    Ou D; Chong P; Tingle AJ; Gillam S
    J Med Virol; 1993 Jul; 40(3):175-83. PubMed ID: 7689090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of rubella virus E1 fusion proteins for detection of rubella virus antibodies.
    Starkey WG; Newcombe J; Corbett KM; Liu KM; Sanders PG; Best JM
    J Clin Microbiol; 1995 Feb; 33(2):270-4. PubMed ID: 7714176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. R237 and h238 are key amino acids in the rubella virus E1 neutralization epitope.
    Li ZM; Chu FL; Wen HL; Sun ZH; Li GH; Xie WY; Wang ZY
    Viral Immunol; 2014 Nov; 27(9):422-9. PubMed ID: 25226223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutralizing monoclonal antibody to the E1 glycoprotein epitope of rubella virus mediates virus arrest in VERO cells.
    Cordoba P; Grutadauria S; Cuffini C; Zapata M
    Viral Immunol; 2000; 13(1):83-92. PubMed ID: 10733171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lassa virus glycoproteins: antigenic and immunogenic properties of synthetic peptides to GP1.
    Krasko AG; Moshnikova AB; Kozhich AT; Tchikin LD; Ivanov VT; Vladyko AS; Lukashevich IS
    Arch Virol; 1990; 115(1-2):133-7. PubMed ID: 1701079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunodominant T-cell epitopes of rubella virus structural proteins defined by synthetic peptides.
    McCarthy M; Lovett A; Kerman RH; Overstreet A; Wolinsky JS
    J Virol; 1993 Feb; 67(2):673-81. PubMed ID: 7678302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human T- and B-cell epitopes of E1 glycoprotein of rubella virus.
    Chaye H; Ou D; Chong P; Gillam S
    J Clin Immunol; 1993 Mar; 13(2):93-100. PubMed ID: 8320313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recognition of contiguous allele-specific peptide elements in the rubella virus E1 envelope protein.
    Nepom GT; Domeier ME; Ou D; Kovats S; Mitchell LA; Tingle AJ
    Vaccine; 1997; 15(6-7):648-52. PubMed ID: 9178465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping and characterization of a sequential epitope on the rabies virus glycoprotein which is recognized by a neutralizing monoclonal antibody, RG719.
    Ni Y; Tominaga Y; Honda Y; Morimoto K; Sakamoto S; Kawai A
    Microbiol Immunol; 1995; 39(9):693-702. PubMed ID: 8577283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.